Why should we need the gut microbiota to respond to cancer therapies? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue OncoImmunology Année : 2014

Why should we need the gut microbiota to respond to cancer therapies?

Résumé

Cyclophosphamide, one of the most efficient tumoricidal, antiangiogenic, and immunostimulatory drugs employed to date mediates part of its effects through intestinal bacteria, against which the host becomes immunized during treatment. Our recent work suggests that anti-commensal effector pT(H)17 and memory T(H)1 CD4(+) T-cell responses are indispensable for optimal anticancer effects as mediated by cyclophosphamide.
Fichier principal
Vignette du fichier
onci-3-e27574.pdf (384.31 Ko) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-01204399 , version 1 (02-11-2016)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Sophie Viaud, Romain Daillere, Takahiro Yamazaki, Patricia Lepage, Ivo Boneca, et al.. Why should we need the gut microbiota to respond to cancer therapies?. OncoImmunology, 2014, 3, ⟨10.4161/onci.27574⟩. ⟨hal-01204399⟩
232 Consultations
91 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More